MX2018011208A - Complejo de capsula dura que contiene dutasterida y tamsulosina y metodo de preparacion del mismo. - Google Patents

Complejo de capsula dura que contiene dutasterida y tamsulosina y metodo de preparacion del mismo.

Info

Publication number
MX2018011208A
MX2018011208A MX2018011208A MX2018011208A MX2018011208A MX 2018011208 A MX2018011208 A MX 2018011208A MX 2018011208 A MX2018011208 A MX 2018011208A MX 2018011208 A MX2018011208 A MX 2018011208A MX 2018011208 A MX2018011208 A MX 2018011208A
Authority
MX
Mexico
Prior art keywords
dutasteride
tamsulosin
independent part
hard capsule
preparation
Prior art date
Application number
MX2018011208A
Other languages
English (en)
Inventor
Hyun Park Jae
Soo Woo Jong
Cheul Kim Jin
Ii Kim Yong
Ho Kim Jae
Joon Lee Benjamin
Original Assignee
Hanmi Pharm Ind Co Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Hanmi Pharm Ind Co Ltd filed Critical Hanmi Pharm Ind Co Ltd
Publication of MX2018011208A publication Critical patent/MX2018011208A/es

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
    • A61K9/4808—Preparations in capsules, e.g. of gelatin, of chocolate characterised by the form of the capsule or the structure of the filling; Capsules containing small tablets; Capsules with outer layer for immediate drug release
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/16—Amides, e.g. hydroxamic acids
    • A61K31/18—Sulfonamides
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/56—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids
    • A61K31/58—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids containing heterocyclic rings, e.g. danazol, stanozolol, pancuronium or digitogenin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
    • A61K9/4816—Wall or shell material
    • A61K9/4825—Proteins, e.g. gelatin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
    • A61K9/4833—Encapsulating processes; Filling of capsules
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
    • A61K9/50—Microcapsules having a gas, liquid or semi-solid filling; Solid microparticles or pellets surrounded by a distinct coating layer, e.g. coated microspheres, coated drug crystals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
    • A61K9/50—Microcapsules having a gas, liquid or semi-solid filling; Solid microparticles or pellets surrounded by a distinct coating layer, e.g. coated microspheres, coated drug crystals
    • A61K9/5005—Wall or coating material
    • A61K9/5021—Organic macromolecular compounds
    • A61K9/5052—Proteins, e.g. albumin
    • A61K9/5057—Gelatin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
    • A61K9/50—Microcapsules having a gas, liquid or semi-solid filling; Solid microparticles or pellets surrounded by a distinct coating layer, e.g. coated microspheres, coated drug crystals
    • A61K9/5084—Mixtures of one or more drugs in different galenical forms, at least one of which being granules, microcapsules or (coated) microparticles according to A61K9/16 or A61K9/50, e.g. for obtaining a specific release pattern or for combining different drugs

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicinal Preparation (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)

Abstract

Un aspecto de la presente divulgación proporciona un complejo de cápsula dura y un método de preparación del mismo, comprendiendo el complejo de cápsula dura, en un estado separado: una parte independiente de dutasterida que comprende dutasterida o una sal farmacéuticamente aceptable de la misma; y una parte independiente de tamsulosina que comprende tamsulosina o una sal farmacéuticamente aceptable de la misma, en el que la parte independiente de dutasterida es una preparación que contiene una emulsion autoemulsionante que consiste en dutasterida, un aceite y un tensioactivo; la parte independiente de tamsulosina es una preparación sólida que contiene un agente de liberación sostenida: y la parte independiente de dutasterida y la parte independiente de tamsulosina se incluyen en un estado separado y se pueden cargar en una capsula de tamaño N. o 0 a 3.
MX2018011208A 2016-03-16 2017-03-16 Complejo de capsula dura que contiene dutasterida y tamsulosina y metodo de preparacion del mismo. MX2018011208A (es)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
KR20160031468 2016-03-16
PCT/KR2017/002862 WO2017160106A2 (ko) 2016-03-16 2017-03-16 두타스테라이드 및 탐수로신 함유 경질 캡슐 복합제 및 그 제조방법

Publications (1)

Publication Number Publication Date
MX2018011208A true MX2018011208A (es) 2019-05-30

Family

ID=59850978

Family Applications (1)

Application Number Title Priority Date Filing Date
MX2018011208A MX2018011208A (es) 2016-03-16 2017-03-16 Complejo de capsula dura que contiene dutasterida y tamsulosina y metodo de preparacion del mismo.

Country Status (8)

Country Link
KR (1) KR101968754B1 (es)
CN (1) CN109152743B (es)
AU (1) AU2017233134A1 (es)
BR (1) BR112018068686A2 (es)
EA (1) EA201891843A1 (es)
MX (1) MX2018011208A (es)
PH (1) PH12018501985A1 (es)
WO (1) WO2017160106A2 (es)

Family Cites Families (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
TW369521B (en) 1993-09-17 1999-09-11 Smithkline Beecham Corp Androstenone derivative
UA80393C2 (uk) 2000-12-07 2007-09-25 Алтана Фарма Аг Фармацевтична композиція, яка містить інгібітор фде 4, диспергований в матриці
DK1618873T3 (da) * 2004-07-14 2007-10-08 Siegfried Generics Int Ag Granulat til kontrolleret frigivelse af tamsulosin, indeholdende alginat
WO2006055659A2 (en) * 2004-11-15 2006-05-26 Smithkline Beecham Corporation Fixed dose combination op dutasteride and tamsulosin
CN102247379A (zh) * 2011-01-12 2011-11-23 北京润德康医药技术有限公司 一种复方制剂及其制备方法
CN102145007B (zh) * 2011-03-03 2013-03-20 王致中 一种非那雄胺软胶囊与盐酸坦索罗辛胶囊复方制剂、所用胶囊及制备方法
WO2014002015A1 (en) * 2012-06-25 2014-01-03 Ranbaxy Laboratories Limited Pharmaceutical composition comprising dutasteride
US20160287524A1 (en) * 2013-03-19 2016-10-06 Galenicum Health S.L. Pharmaceutical compositions comprising an active agent
WO2014203137A2 (en) * 2013-06-21 2014-12-24 Wockhardt Limited Pharmaceutical compositions of tamsulosin or salts thereof
EP2949319A1 (en) * 2014-05-26 2015-12-02 Galenicum Health S.L. Pharmaceutical compositions comprising an active agent
KR101590072B1 (ko) * 2014-12-23 2016-01-29 한미약품 주식회사 두타스테라이드를 포함하는 자가유화 약물전달 시스템용 조성물

Also Published As

Publication number Publication date
CN109152743A (zh) 2019-01-04
WO2017160106A3 (ko) 2018-09-07
CN109152743B (zh) 2022-01-07
PH12018501985A1 (en) 2019-07-08
KR101968754B1 (ko) 2019-04-12
BR112018068686A2 (pt) 2019-01-15
WO2017160106A2 (ko) 2017-09-21
KR20170107933A (ko) 2017-09-26
EA201891843A1 (ru) 2019-04-30
AU2017233134A1 (en) 2018-10-04

Similar Documents

Publication Publication Date Title
MX2021001583A (es) Formas sólidas cristalinas de n-{4-[(6,7-dimetoxiquinolin-4-il)oxi ] fenil}-n'-(4-fluorofenil)ciclopropan-1,1-dicarboxamida, procesos para elaboración y métodos de uso.
BR112016022159B8 (pt) Pó e método para melhorar a aplicação tópica de um agente de benefício ácido
BR112017010332A2 (pt) composição, e, método de tratamento de formação subterrânea
EA201992020A1 (ru) Фармацевтический комбинированный состав капсулы, содержащий тадалафил и тамсулозин
MX2021001905A (es) Preparacion farmaceutica que tiene excelentes propiedades de disolucion, que contiene esomeprazol y bicarbonato de sodio.
TW201613632A (en) Brain function improving agent, and prophylactic or therapeutic agent for cognitive dysfunction
IN2013CH05441A (es)
IN2014MU01042A (es)
HK1253288A1 (zh) 用於製備水性物質的球形膠囊的方法和通過所述方法獲得的膠囊
MX2017003082A (es) Composiciones farmaceuticas resistentes al abuso.
IL291953A (en) Formulations of non-animal soft gel capsules, methods of preparation and methods of use thereof
PH12019500919A1 (en) Esomeprazole~containing complex capsule and preparation method therefor
PH12018501985A1 (en) Dutasteride-and tamsulosin-containing hard capsule complex and preparation method therefor
EP3416626A4 (en) MICROSPHERES CONTAINING THERAPEUTIC AGENTS AND ASSOCIATED METHODS OF USE
EP3648745A4 (en) PHARMACEUTICAL COMPOSITION CONSISTING OF A MULTI-UNIT SPHEROIDAL TABLET CONTAINING ESOMEPRAZOLE AND A PHARMACEUTICAL SALT OF THE SAME, AND PROCESS FOR THE PREPARATION OF THE PHARMACEUTICAL COMPOSITION
CL2018001151A1 (es) Suspensión acuosa para administración oral y método para su preparación
EA202090913A1 (ru) Композиция таблеток с модифицированным высвобождением, содержащая мирабегрон
TN2014000152A1 (en) Sustained-release preparation
MX2017009799A (es) Capsulas compuestas que comprenden raloxifeno y vitamina d o sus derivados.
MX2022000803A (es) Formulaciones de capsula de cubierta blanda y metodos de preparacion y uso de las mismas.
MX2019006939A (es) Preparacion liquida parenteral que comprende compuesto de carbamato.
IT201700037229A1 (it) Dispositivo per l'apertura di capsule contenenti preparati per bevande
TR201722186A2 (tr) Dabi̇gatranin farmasöti̇k kompozi̇syonlari
MX2015011152A (es) Composicion farmaceutica de omeprazol-bicarbonato de sodio para integrar una capsula, para el tratamiento de alopatias relacionadas con la acidez gastrica.
TH165164A (th) สูตรผสมเชิงประกอบทางเภสัชกรรมของแคปซูลที่ประกอบรวมด้วยทาดาลาฟิล และแทมซูโลซิน